AskAt received an Issue Notification dated April 22, 2026 from the U.S. Patent and Trademark Office (USPTO) for a salt and crystal forms patent for its CB2 agonist, AAT-730 (Patent Number: 12,617,776). The notice was issued in connection with US Patent Application No. 18/595,742 (Filing Date: November 11, 2021), which stems from a continuation application for US Patent Application No. 18/035,195. In addition to our granted U.S. patent for a salt and crystal forms of AAT-730 (Patent Number:11,964,963), this approval further solidifies our IP position for AAT-730 in the U.S.